| Filed On | Filing |
|---|---|
| 27 Jun 2014 |
8-K/A: Submission of Matters to a Vote of Security Holders
Sarepta Therapeutics, Inc. (the “Company”) is filing this Amendment No. 1 to the current report on Form 8-K it filed on June 6, 2014 to update the final voting results reported for each proposal presented at the Company’s Annual Meeting ... |
| 04 Oct 2012 |
8-K/A: Other Events
CAMBRIDGE, MA, October 3, 2012 – Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, received notice from the U.S. Department of Defense (DoD) that the Ebola portion of the Company’s contract for ... |
| 24 May 2010 |
8-K/A: Departure/Election of Directors or Officers; Compensation
The following table identifies the options held by Dr. Hudson as of April 20, 2010, the vesting of all of which was automatically accelerated upon the effective date of his termination without cause in accordance with Dr. Hudson’s Employ... |
| 20 May 2003 |
8-K/A: Other Events
On May 5, 2003, AVI BioPharma, Inc. (NASDAQ: AVII, AVIIW, AVIIZ) (the “Company”) announced a private placement of 3,000,000 shares of its common stock, par value $.0001 per share (the “Common Stock”), together with warrants to acquire an... |
| 09 May 2003 |
8-K/A: Other Events
This Securities Purchase Agreement (this “Agreement”) is dated as of May 5, 2003 among AVI BioPharma, Inc., an Oregon corporation (the “Company”), and each purchaser identified on the signature pages hereto (each a “Purchaser” and collec... |
| 10 Jun 2002 |
8-K/A: Changes in Registrant's Certifying Accountant; Other Events
AVI Contacts: AVI BioPharma, Inc. Denis R. Burger, Ph.D., CEO Alan P. Timmins, President and COO (503) 227-0554 |
| 31 May 2002 |
8-K/A: Changes in Registrant's Certifying Accountant; Other Events
QuickLinks -- Click here to rapidly navigate through this document |
Loading...